Ontology highlight
ABSTRACT:
SUBMITTER: Rujkijyanont P
PROVIDER: S-EPMC3763390 | biostudies-literature | 2013 Aug
REPOSITORIES: biostudies-literature
Rujkijyanont P P Morris C C Kang G G Gan K K Hartford C C Triplett B B Dallas M M Srinivasan A A Shook D D Pillai A A Pui C-H CH Leung W W
Blood cancer journal 20130830
Donor lymphocyte infusion (DLI) is commonly used to treat leukemia relapse following stem cell transplantation. In florid relapse, however, the efficacy of DLI is limited with substantial risk of severe graft-versus-host disease (GvHD). Here, we develop a novel risk-adapted strategy characterized by pre-emptive DLI initiated at the time of mixed chimerism, a small starting dose based on donor source, dose-escalation guided by real-time chimerism monitoring and withholding of DLI immediately in p ...[more]